Oral Presentations—Abstracts
Martin Bartsch, Timo L.M. ten Hagen(Erasmus MC), Kristine Romøren(University of Oslo), Masaharu Miyajima(Terumo (Japan)), Göran Karlsson(Uppsala University), Otto C. Boerman(Breast Cancer Research Foundation), Ning Hu(Hebei Medical University), Katarina Edwards(Uppsala University), Mirco Ponzoni(Istituto Giannina Gaslini), G. Molema(University of Groningen), P.L. van Lent(University Medical Center), Raymond M. Schiffelers(University Medical Center Utrecht), Giacomo Martini(University of Florence), Hasan Bilgili(Ankara University), Azumi Sekiguchi(Terumo (Japan)), T. M. Allen(University of Alberta), L. D. Mayer(BC Cancer Agency), Simona W. Rossi(University of Florence), Danilo Marimpietri(Istituto Giannina Gaslini), Gerben A. Koning(Università Cattolica del Sacro Cuore), Josbert M. Metselaar(Universitätsklinikum Aachen), Gerrit L. Scherphof(University Medical Center Groningen), Junji Kimura(Utrecht University), Fabio Pastorino(Istituto Giannina Gaslini), Marca H. M. Wauben(University of Applied Sciences Utrecht), Elaine H. Moase(University of Alberta), Jan A. A. M. Kamps(University Medical Center Groningen), Emiko Kiyoki(Terumo (Japan)), Junji Kimura(Utrecht University), Sandra Ristori(University of Florence), Ludger M. Ickenstein(BC Cancer Agency), Serpil Erdoğan(Ankara Numune Eğitim ve Araştırma Hastanesi), Dirk K. F. Meijer(University of Groningen), Kazuhiro Morimoto(Terumo (Japan)), K. Kawahara(Terumo (Japan)), Beate Thu, Gert Storm(Yong In University), B Caner(Hacettepe University), H.W.M. Morselt(University of Groningen), Øystein Evensen, Gerard M. Jensen(Gilead Sciences (United States)), Chiara Brignole(Istituto Giannina Gaslini), A. Yekta Özer(Hacettepe University), Crispin G. S. Eley(Gilead Sciences (United States))
Cited by 1
Related Papers
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
|Frontiers in Pharmacology|2018|937
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
TNF-α in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility
|The Oncologist|2006|711
Sheddable Coatings for Long-Circulating Nanoparticles
|Pharmaceutical Research|2007|549
MIFlowCyt‐EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments
|Journal of Extracellular Vesicles|2020|514